These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 87990)

  • 1. Intravenous heparin initiates in-vivo synthesis and release of thromboxane in angina pectoris.
    Lewy RI; Wiener L; Smith JB; Walinsky P; Silver MJ
    Lancet; 1979 Jul; 2(8133):97. PubMed ID: 87990
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of plasma concentrations of thromboxane B2 in Prinzmetal's variant angina and classical angina pectoris.
    Lewy RI; Wiener L; Smith JB; Walinsky P; Silver MJ; Saia J
    Clin Cardiol; 1979 Dec; 2(6):404-6. PubMed ID: 544110
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's angina.
    Lewy RI; Smith JB; Silver MJ; Saia J; Walinsky P; Wiener L
    Prostaglandins Med; 1979 Apr; 2(4):243-8. PubMed ID: 575861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of elevated plasma-free fatty acids on thromboxane release in patients with coronary artery disease.
    Lewy RI
    Haemostasis; 1980; 9(3):134-40. PubMed ID: 7372200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of thromboxane B2 levels in patients with classic and variant angina Pectoris.
    Tada M; Kuzuya T; Inoue M; Kodama K; Mishima M; Yamada M; Inui M; Abe H
    Circulation; 1981 Dec; 64(6):1107-15. PubMed ID: 7296786
    [No Abstract]   [Full Text] [Related]  

  • 6. Humoral heartache -- do platelets have a role?
    Handin RI; Alexander RW
    N Engl J Med; 1981 Apr; 304(17):1035-6. PubMed ID: 7010170
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of thromboxanes in vasotonic versus vaso-occlusive angina.
    Lewy RI
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():13-6. PubMed ID: 6407435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levels of neuropeptide Y and thromboxane B2 in patients with variant angina].
    Salomon P; Halawa B
    Pol Arch Med Wewn; 1998 Oct; 100(4):313-20. PubMed ID: 10335040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of thromboxane A2 in myocardial ischemia in patients with coronary artery disease.
    Tada M; Kuzuya T; Inoue M; Kodama K; Fukushima M; Abe H
    Adv Myocardiol; 1980; 2():397-405. PubMed ID: 7423053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary spasm, prostaglandin and HLA factors.
    Numano F; Aizawa T; Nomura S; Yajima M; Fujii J
    Jpn Circ J; 1985 Jan; 49(1):119-27. PubMed ID: 3855470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxane release in coronary artery disease: spontaneous versus pacing-induced angina.
    Mehta J; Mehta P; Feldman RL; Horalek C
    Am Heart J; 1984 Feb; 107(2):286-92. PubMed ID: 6695662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolism of several blood prostaglandins in patients with angina pectoris during helium-neon laser therapy].
    Babushkina GV; Shaĭmukhametova LT; Korochkin IM; Kartelishev AV; Kapustina GM; Mingazetdinova LN
    Kardiologiia; 1993; 33(2):12-5. PubMed ID: 8084118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.
    Robertson RM; Robertson D; Roberts LJ; Maas RL; FitzGerald GA; Friesinger GC; Oates JA
    N Engl J Med; 1981 Apr; 304(17):998-1003. PubMed ID: 7010173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased platelet aggregation but increased thromboxane A2 generation in polycythemia vera.
    Mehta P; Mehta J; Ross M; Ostrowski N; Player D
    Arch Intern Med; 1985 Jul; 145(7):1225-7. PubMed ID: 4015270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biochemistry of coronary artery disease--prostaglandins].
    Tada M; Kuzuya T; Ohmori M
    Rinsho Byori; 1983 Aug; 31(8):854-9. PubMed ID: 6361336
    [No Abstract]   [Full Text] [Related]  

  • 16. Thromboxane-B2 generation during ex-vivo platelet aggregation.
    De Caterina R; Giannessi D; Gazzetti P; Bernini W
    J Nucl Med Allied Sci; 1984; 28(3):185-96. PubMed ID: 6530623
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of provocation on transcardiac thromboxane in patients with coronary artery disease.
    Hirsh PD; Firth BG; Campbell WB; Dehmer GJ; Willerson JT; Hillis LD
    Am J Cardiol; 1983 Mar; 51(5):727-33. PubMed ID: 6829431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of ethanol, caffeine, or both on platelet aggregation, thromboxane formation, and plasma-free fatty acids in normal subjects.
    Galli C; Colli S; Gianfranceschi G; Maderna P; Petroni A; Tremoli E; Marinovich M; Sirtori CR
    Drug Nutr Interact; 1984; 3(1):61-7. PubMed ID: 6510241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet thromboxanes and serum-cholesterol.
    Tremoli E; Folco G; Agradi E; Galli C
    Lancet; 1979 Jan; 1(8107):107-8. PubMed ID: 84115
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of the complex treatment of stable stenocardia on the status of the prostacyclin-thromboxane system].
    Khimenko PL
    Ter Arkh; 1986; 58(5):95-8. PubMed ID: 2874621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.